We are live on ! Find out more
HZNP

Horizon Therapeutics Public Limited Company Ordinary Shares

Delisted

HZNP was delisted on the 5th of October, 2023.

6 hedge funds and large institutions have $49.4K invested in Horizon Therapeutics Public Limited Company Ordinary Shares in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 474 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 4856 (-479)

100% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 474

100% less funds holding in top 10

Funds holding in top 10: 800 (-80)

100% less capital invested

Capital invested by funds: $24.8B → $49.4K (-$24.8B)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
6
Holders Change
-479
Holders Change %
-98.76%
% of All Funds
0.09%
Holding in Top 10
Holding in Top 10 Change
-80
Holding in Top 10 Change %
-100%
% of All Funds
New
2
Increased
Reduced
1
Closed
474
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
NGM
126
North Growth Management
British Columbia, Canada
-$18.9M -163,000 Closed
Mitsubishi UFJ Trust & Banking
127
Mitsubishi UFJ Trust & Banking
Japan
-$18M -155,428 Closed
AGC
128
Angelo Gordon & Co
New York
-$17.9M -155,000 Closed
Bank of Montreal
129
Bank of Montreal
Ontario, Canada
-$17.7M -153,685 Closed
FIA
130
FNY Investment Advisers
New York
-$16.7M -144,340 Closed
Canada Pension Plan Investment Board
131
Canada Pension Plan Investment Board
Ontario, Canada
-$16.6M -143,547 Closed
Ohio Public Employees Retirement System (OPERS)
132
Ohio Public Employees Retirement System (OPERS)
Ohio
-$16.3M -140,586 Closed
PCM
133
Prelude Capital Management
New York
-$15.7M -135,854 Closed
HF
134
HRT Financial
New York
-$15.6M -134,760 Closed
Janus Henderson Group
135
Janus Henderson Group
United Kingdom
-$15.6M -134,617 Closed
Russell Investments Group
136
Russell Investments Group
United Kingdom
-$15.5M -133,657 Closed
YCM
137
Yakira Capital Management
Connecticut
-$15.3M -131,873 Closed
GLAM
138
Gardner Lewis Asset Management
Pennsylvania
-$15.2M -131,142 Closed
T. Rowe Price Associates
139
T. Rowe Price Associates
Maryland
-$15M -129,492 Closed
M
140
Murchinson
Ontario, Canada
-$14.8M -128,171 Closed
Public Sector Pension Investment Board (PSP Investments)
141
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
-$14.8M -128,000 Closed
Grantham, Mayo, Van Otterloo & Co (GMO)
142
Grantham, Mayo, Van Otterloo & Co (GMO)
Massachusetts
-$14.3M -123,376 Closed
State of New Jersey Common Pension Fund D
143
State of New Jersey Common Pension Fund D
New Jersey
-$14.2M -122,786 Closed
Nisa Investment Advisors
144
Nisa Investment Advisors
Missouri
-$14.1M -122,131 Closed
VOYA Investment Management
145
VOYA Investment Management
Georgia
-$14.1M -121,588 Closed
Ameriprise
146
Ameriprise
Minnesota
-$14M -120,430 Closed
FSI
147
Flow State Investments
Illinois
-$13.9M -119,935 Closed
AC
148
Athos Capital
Hong Kong
-$13.6M -117,638 Closed
SVCM
149
Saturn V Capital Management
Texas
-$12.8M -111,045 Closed
AQR Capital Management
150
AQR Capital Management
Connecticut
-$12.7M -109,883 Closed

HZNP Hedge Fund Activity: Q4 2023 in Review

6 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) for Q4 2023, worth a combined $49.4K — down 100% from $24.8B a quarter earlier.

Sellers outnumbered buyers: 474 funds closed out of HZNP and 2 opened new positions — a net loss of 472 holders — while 1 trimmed existing stakes and 0 added.

The largest buyer was Blue Trust Inc, opening a new position worth an estimated $4.88K. The largest seller was Vanguard Group, exiting entirely with an estimated $2.5B sold.

  • 6 institutional investors held Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) as of Q4 2023, down from 485 in Q3 2023.
  • Funds reported $49.4K of Horizon Therapeutics Public Limited Company Ordinary Shares stock for Q4 2023, down 100% quarter-over-quarter.
  • 2 funds opened new Horizon Therapeutics Public Limited Company Ordinary Shares positions in Q4 2023 and 474 closed out, a net change of -472 holders.
  • The largest Horizon Therapeutics Public Limited Company Ordinary Shares buyer in Q4 2023 was Blue Trust Inc, an estimated $4.88K added.
  • The largest Horizon Therapeutics Public Limited Company Ordinary Shares seller in Q4 2023 was Vanguard Group, an estimated $2.5B sold.

Based on aggregated 13F filings for Q4 2023.